Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Hormonal contraception

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44339   clinical trials with a EudraCT protocol, of which   7369   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    3,120 result(s) found for: Hormonal contraception. Displaying page 1 of 156.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    EudraCT Number: 2012-002220-32 Sponsor Protocol Number: 225/2611 Start Date*: 2012-06-13
    Sponsor Name:OYS
    Full Title: The effects of contraceptive pill and hormonal vaginal ring on hormonal, inflammatory and metabolic parameters in women of reproductive age with polycystic ovary syndrome (PCOS).
    Medical condition: Polycystic Ovary Syndrome (PCOS)
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: FI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2012-005640-14 Sponsor Protocol Number: 42994 Start Date*: 2013-04-15
    Sponsor Name:Erasmus MC
    Full Title: The effects of hormonal contraception on the HPA-axis functioning
    Medical condition: healthy female volunteers; hormonal contraception method used: combined method (oestrogens en progestins) and progesterone-only method.
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004865 10010812 Contraceptive methods female HLT
    Population Age: Adults Gender: Female
    Trial protocol: NL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-004544-73 Sponsor Protocol Number: 311623 Start Date*: 2008-01-23
    Sponsor Name:Bayer Schering Pharma AG
    Full Title: A double-blind, randomized, uncontrolled study to evaluate inhibition of ovulation of two oral estradiol / drospirenone regimens in healthy young female volunteers over a period of 3 treatment cycles
    Medical condition: The trial will be performed in healthy female volunteers. The intended indication is female contraception.
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2007-005258-22 Sponsor Protocol Number: 311926 Start Date*: 2008-02-26
    Sponsor Name:Bayer Schering Pharma AG
    Full Title: A multi-center, double-blind, randomized, parallel-group study to evaluate cycle control and safety of 6 different regimens of an oral contraceptive containing estradiol and drospirenone in healthy...
    Medical condition: The trial will be performed in healthy female volunteers. The intended indication is female contraception.
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2007-007489-39 Sponsor Protocol Number: 2007-12-01 Start Date*: 2008-03-25
    Sponsor Name:University of Hamburg, MIN-Faculty, Department of Chemistry, Division of Cosmetetic Science
    Full Title: Effects of the oral monophasic contraceptive pill CG 5025 (Belara/0,03 mg etinyl estradiol and 2 mg chlormadinonacetate) on the cosmetic hairquality in women wishing to use hormonal contraception
    Medical condition: unaesthetic hairquality in woman wishing to use hormonal contraception
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2020-000412-30 Sponsor Protocol Number: LF111/401 Start Date*: Information not available in EudraCT
    Sponsor Name:Chemo Research S.L.
    Full Title: A multicenter, open-label, controlled study to investigate the effect of either LF111 or Drospirenone chewable tablets on bone mineral density (BMD) in adolescent and adult women in comparison with...
    Medical condition: Oral contraception
    Disease: Version SOC Term Classification Code Term Level
    21.0 10022891 - Investigations 10049470 Bone density decreased PT
    Population Age: Adolescents, Under 18, Adults Gender: Female
    Trial protocol: CZ (Trial now transitioned) PL (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2006-003387-55 Sponsor Protocol Number: 2914-004 Start Date*: 2007-11-15
    Sponsor Name:Laboratoire HRA Pharma
    Full Title: " A Prospective, Randomized, Single Blind, Multicenter Study to Compare the Efficacy, Safety and Tolerability of CDB-2914 with Levonorgestrel as Emergency Contraception Within 120 Hours Unprotected...
    Medical condition: Emergency contraception
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: IE (Completed) GB (Completed)
    Trial results: View results
    EudraCT Number: 2021-003027-15 Sponsor Protocol Number: EFFI2021/01 Start Date*: 2023-03-20
    Sponsor Name:ITALFARMACO S.P.A.
    Full Title: A multicentre, prospective, open-label, non-comparative study to evaluate menstrual bleeding typology, tolerability, and compliance during a monophasic hormonal contraceptive treatment with norgest...
    Medical condition: Combined Oral Contraceptives (COC)
    Disease: Version SOC Term Classification Code Term Level
    20.0 10014698 - Endocrine disorders 10014698 Endocrine disorders SOC
    Population Age: Adults Gender: Female
    Trial protocol: IT (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2019-001876-12 Sponsor Protocol Number: LPRI-424/301 Start Date*: 2019-12-16
    Sponsor Name:Chemo Research S.L.
    Full Title: A multicentre, uncontrolled trial on the contraceptive efficacy, safety, tolerability and pharmacokinetics of LPRI-424 (dienogest 2 mg / ethinyl estradiol 0.02 mg) during 13 cycles
    Medical condition: Oral contraception for females aged 18-45
    Disease: Version SOC Term Classification Code Term Level
    20.0 10042613 - Surgical and medical procedures 10042613 Surgical and medical procedures SOC
    21.1 10042613 - Surgical and medical procedures 10030970 Oral contraception PT
    Population Age: Adults Gender: Female
    Trial protocol: DE (Completed) LT (Completed) PT (Not Authorised) ES (Completed) BG (Completed) CZ (Completed)
    Trial results: (No results available)
    EudraCT Number: 2018-000128-33 Sponsor Protocol Number: 17700 Start Date*: 2018-05-18
    Sponsor Name:Bayer AG
    Full Title: Multi-center, randomized, comparator-controlled, single-blind, parallel-group study to investigate the pharmacodynamics, pharmacokinetics and safety of an intrauterine system (BAY 987443) with thre...
    Medical condition: Contraception
    Disease: Version SOC Term Classification Code Term Level
    20.0 10042613 - Surgical and medical procedures 10073728 Hormonal contraception LLT
    20.0 10042613 - Surgical and medical procedures 10010808 Contraception PT
    Population Age: Adults Gender: Female
    Trial protocol: DE (Completed) GB (Completed)
    Trial results: View results
    EudraCT Number: 2011-004085-15 Sponsor Protocol Number: CF111/203 Start Date*: 2011-11-04
    Sponsor Name:Laboratories León Farma S.A
    Full Title: Open-Label, Randomized Study to Evaluate the Influence on the Hormonal and Ovarian Activity of Two Different Dosages of Drospirenone (either 4.0 mg for 24 Days or 2.8 mg Daily for 28 Days) Over Two...
    Medical condition: Evaluation of the influence of Drosperinone on the hormonal and ovarian activity, the bleeding pattern and the endometrial thickness.
    Disease: Version SOC Term Classification Code Term Level
    14.0 10042613 - Surgical and medical procedures 10030970 Oral contraception PT
    Population Age: Adults Gender: Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2009-015059-26 Sponsor Protocol Number: 510460 Start Date*: 2010-08-19
    Sponsor Name:Actavis GmbH & Co. KG
    Full Title: Efficacy of 12 weeks oral Pentalong® on Exercise Capacity and Quality of Life in Patients With Systolic Heart Failure and Secondary Pulmonary Hypertension Short title: CAESAR Clinical efficacy ...
    Medical condition: Woman and men suffering from heart failure NYHA II-IV and secondary pulmonary hypertension Objectives PVR improvement after a 12 week oral Pentalong® therapy in addition to standard long-term HF...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2011-002396-42 Sponsor Protocol Number: CF111/302 Start Date*: 2012-02-09
    Sponsor Name:Laboratorios León Farma S.A.
    Full Title: A Pivotal, Multicentre, Double-Blind, Double-Dummy, Randomised Trial on the Contraceptive Efficacy, Tolerability and Safety of LF111 (Drospirenone) Over 9 Cycles in Comparison With Desogestrel 0.07...
    Medical condition: Oral hormonal contraceptive for women without uncontrolled current diseases between 18-45 years.
    Disease: Version SOC Term Classification Code Term Level
    15.1 10042613 - Surgical and medical procedures 10030970 Oral contraception PT
    Population Age: Adults Gender: Female
    Trial protocol: DE (Completed) HU (Completed) CZ (Completed) AT (Completed) ES (Completed) SK (Completed)
    Trial results: View results
    EudraCT Number: 2014-001243-20 Sponsor Protocol Number: SYLVI030785 Start Date*: 2014-06-11
    Sponsor Name:Helsinki University Central Hospital
    Full Title: Syntethic vs. natural estrogen in combined oral contraception- effect on insulinsensitivity, inflammation, coagulation and endometrium. A comparison with a progestin-only preparation.
    Medical condition: Healthy women, contraception
    Disease: Version SOC Term Classification Code Term Level
    17.0 100000004865 10073728 Hormonal contraception LLT
    Population Age: Adults Gender: Female
    Trial protocol: FI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2019-001877-97 Sponsor Protocol Number: LPRI-424/302 Start Date*: 2020-02-19
    Sponsor Name:Chemo Research S.L.
    Full Title: A multicentre, double-blind, double-dummy, randomised trial on the contraceptive efficacy, tolerability and safety of LPRI-424 (dienogest 2 mg / ethinyl estradiol 0.02 mg) during nine cycles in com...
    Medical condition: Oral contraception for females aged 18-45
    Disease: Version SOC Term Classification Code Term Level
    20.0 10042613 - Surgical and medical procedures 10042613 Surgical and medical procedures SOC
    21.1 10042613 - Surgical and medical procedures 10030970 Oral contraception PT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Completed) CZ (Completed) SK (Completed) HU (Completed) PT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2018-003347-28 Sponsor Protocol Number: MK-1654-005 Start Date*: 2019-10-03
    Sponsor Name:Merck Sharp & Dohme Corp
    Full Title: A Phase 2a Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-1654 in Healthy Participants Inoculated with Experimental Respiratory Syncytial Virus.
    Medical condition: Respiratory Syncytial Virus Infection
    Disease: Version SOC Term Classification Code Term Level
    21.1 10021881 - Infections and infestations 10061603 Respiratory syncytial virus infection PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: View results
    EudraCT Number: 2018-003921-27 Sponsor Protocol Number: DORAGEN Start Date*: 2019-06-25
    Sponsor Name:Lluita contra la SIDA Foundation
    Full Title: Doravirine concentrations and antiviral activity in genital fluids in HIV-1 infected individuals.
    Medical condition: HIV infected individuals
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: View results
    EudraCT Number: 2010-023543-15 Sponsor Protocol Number: CL09002 Start Date*: 2011-01-24
    Sponsor Name:BioCis Pharma Oy
    Full Title: Double-blind, placebo-controlled, multi-centre Phase II study to investigate dose response, safety, tolerability and efficacy of topical twice daily doses of 2.5% and 5% cis-urocanic acid in compar...
    Medical condition: Chronic moderate or severe atopic dermatitis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-008332-90 Sponsor Protocol Number: CL08004 Start Date*: 2009-02-10
    Sponsor Name:BioCis Pharma Oy
    Full Title: Double-blind, vehicle-controlled, single centre Phase I/IIa study with topical twice daily doses of 5% cis-urocanic acid to investigate pharmacokinetics, safety, tolerability, and efficacy for up t...
    Medical condition: Mild to moderate plaque psoriasis
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-005075-10 Sponsor Protocol Number: CL08002 Start Date*: 2008-10-01
    Sponsor Name:BioCis Pharma Oy
    Full Title: Double-blind, vehicle-controlled, two-phase, single centre Phase I/IIa study with topical twice daily doses of 5% cis-urocanic acid to investigate pharmacokinetics, safety, tolerability and efficac...
    Medical condition: Chronic mild to moderate atopic dermatitis
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Wed May 28 22:05:56 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA